Literature DB >> 15042129

Soyfood consumption and risk of glycosuria: a cross-sectional study within the Shanghai Women's Health Study.

G Yang1, X O Shu, F Jin, T Elasy, H L Li, Q Li, F Huang, X L Zhang, Y T Gao, W Zheng.   

Abstract

OBJECTIVE: To assess the association between soyfood intake and risk of glycosuria. DESIGN AND METHODS: A cross-sectional study was conducted among participants of the Shanghai Women's Health Study, a population-based cohort study of women aged 40-70 y. Information on usual intake of soyfoods was obtained at baseline survey through an in-person interview using a validated food-frequency questionnaire. Included in this study were 39,385 cohort members screened for diabetes at the baseline survey and free of previously diagnosed diabetes, cardiovascular diseases, kidney diseases, and cancer. There were 323 women who tested positive for urine glucose. Odds ratios (ORs) and 95% confidence intervals (CIs) were employed to measure the association between soyfood intake and glycosuria using unconditional logistic regression.
SETTING: Urban communities of Shanghai, China.
RESULTS: Overall, soyfood intake was not related to the risk of glycosuria. Among postmenopausal women, however, intake of tofu and other soy products was inversely associated with risk of glycosuria after adjustment for potential confounders. The ORs across quintiles of intake were 1.0, 0.75 (95% CI=0.47-1.20), 0.79 (95% CI=0.51-1.25), 0.53 (95% CI=0.32-0.88), and 0.51 (95% CI=0.26-0.98; P for trend=0.05). Further analyses showed that the inverse association was primarily confined to postmenopausal women with a body mass index (BMI) of <25 kg/m2. The adjusted OR comparing the extreme quintiles was 0.36 (95% CI=0.13-0.97; P for trend=0.004).
CONCLUSIONS: Soyfoods may play a role in the development of glycosuria, an important indicator of diabetes, among postmenopausal women with a low BMI.

Entities:  

Mesh:

Year:  2004        PMID: 15042129     DOI: 10.1038/sj.ejcn.1601855

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  8 in total

Review 1.  Role of phytoestrogens in prevention and management of type 2 diabetes.

Authors:  Mohammad Talaei; An Pan
Journal:  World J Diabetes       Date:  2015-03-15

2.  Soyfood and isoflavone intake and risk of type 2 diabetes in Vietnamese adults.

Authors:  C T Nguyen; N M Pham; V V Do; C W Binns; V M Hoang; D A Dang; A H Lee
Journal:  Eur J Clin Nutr       Date:  2017-05-10       Impact factor: 4.016

3.  Urinary isoflavone concentrations are inversely associated with cardiometabolic risk markers in pregnant U.S. women.

Authors:  Ling Shi; Heather Harker Ryan; Emily Jones; Tiffany A Moore Simas; Alice H Lichtenstein; Qi Sun; Laura L Hayman
Journal:  J Nutr       Date:  2013-12-31       Impact factor: 4.798

4.  Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study.

Authors:  Raquel Villegas; Yu-Tang Gao; Gong Yang; Hong-Lan Li; Tom A Elasy; Wei Zheng; Xiao Ou Shu
Journal:  Am J Clin Nutr       Date:  2008-01       Impact factor: 7.045

5.  The association between urinary phytoestrogen excretion and components of the metabolic syndrome in NHANES.

Authors:  Tristan Struja; Aline Richard; Jakob Linseisen; Monika Eichholzer; Sabine Rohrmann
Journal:  Eur J Nutr       Date:  2013-12-31       Impact factor: 5.614

Review 6.  Targeting Abdominal Obesity and Its Complications with Dietary Phytoestrogens.

Authors:  Alina Kuryłowicz; Marta Cąkała-Jakimowicz; Monika Puzianowska-Kuźnicka
Journal:  Nutrients       Date:  2020-02-23       Impact factor: 5.717

7.  Gynura procumbens Extract Alleviates Postprandial Hyperglycemia in Diabetic Mice.

Authors:  Sung-In Choi; Mi Hwa Park; Ji-Sook Han
Journal:  Prev Nutr Food Sci       Date:  2016-09-30

Review 8.  Phytochemicals as Potential Epidrugs in Type 2 Diabetes Mellitus.

Authors:  Karina Ramírez-Alarcón; Montserrat Victoriano; Lorena Mardones; Marcelo Villagran; Ahmed Al-Harrasi; Ahmed Al-Rawahi; Natália Cruz-Martins; Javad Sharifi-Rad; Miquel Martorell
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-01       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.